IDXX - IDEXX Laboratories, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
IDEXX Laboratories, Inc.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.
IPO Date: January 3, 1994
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $40.43B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.81 | 1.22%
Avg Daily Range (30 D): $7.16 | 1.36%
Avg Daily Range (90 D): $7.93 | 1.44%
Institutional Daily Volume
Avg Daily Volume: .36M
Avg Daily Volume (30 D): .35M
Avg Daily Volume (90 D): .42M
Trade Size
Avg Trade Size (Sh.): 52
Avg Trade Size (Sh.) (30 D): 17
Avg Trade Size (Sh.) (90 D): 19
Institutional Trades
Total Institutional Trades: 28,292
Avg Institutional Trade: $4.8M
Avg Institutional Trade (30 D): $11.3M
Avg Institutional Trade (90 D): $7.77M
Avg Institutional Trade Volume: .02M
Avg Institutional Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $21.61M
Avg Closing Trade (30 D): $62.49M
Avg Closing Trade (90 D): $67.63M
Avg Closing Volume: 66.92K
 
News
Sep 28, 2026 @ 2:00 PM
Veterinary Diagnostics Market Size to Soar to USD ...
Source: Sns Insider
Sep 7, 2026 @ 10:38 AM
Veterinary Diagnostic Markets Report Now Available...
Source: Researchandmarkets.Com
Aug 25, 2026 @ 6:53 PM
Global Veterinary Medical Devices Market to Reach ...
Source: Bcc Research
Jul 17, 2026 @ 12:48 PM
Global Livestock Monitoring Market to Reach $10.3 ...
Source: Bcc Research
Jul 13, 2026 @ 11:32 AM
Veterinary Lab Automation Global Market Report 202...
Source: Researchandmarkets.Com
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $14.33 $4.29 $3.5
Diluted EPS $14.23 $4.27 $3.47
Revenue $4.55B $1.22B $1.14B
Gross Profit $2.84B $779.09M $722.74M
Net Income / Loss $1.14B $338.41M $278.45M
Operating Income / Loss $1.46B $425.57M $362.59M
Cost of Revenue $1.71B $437.5M $418.08M
Net Cash Flow $32.34M $-3.6M $20.46M
PE Ratio    
Splits
Jun 16, 2015 2:1
Nov 27, 2007 2:1